Skip to main content
Log in

Temporal Investigation of Matrix Metalloproteinases and Their Inhibitors in Human Cervicovaginal Fluid in Late Pregnancy and Labor

  • Original Articles
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Temporal expression of matrix metalloproteinase (MMP)-1, -2, -3, -7, -8, -9, -12, and -13, and tissue inhibitors of metalloproteinases (TIMPs)-1 and -2 in human cervicovaginal fluid (CVF) in term pregnancy and labor was investigated. Term parous women provided CVF samples that were grouped into labor, 1 to 3, 6 to 8, and 12 to 16 days before labor onset. Both MMPs and TIMPs (n = 60) were quantified using multiplex solution array and enzyme-linked immunosorbent assays, respectively. Further analysis of TIMP-1 (n = 180) was undertaken. All MMPs and TIMPs except MMP-12 and -13 were detected in the CVF. Matrix metalloproteinase 7, TIMP-1, and TIMP-2 were significantly increased in labor. Tissue inhibitors of metalloproteinase 1 was significantly increased up to 7 days before spontaneous labor onset. The data suggest a role of MMP-7 in the remodeling and rupture of fetal membranes and may reflect the homeostatic regulation of extracellular matrix remodeling of MMP-7 by TIMP-1 and TIMP-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007;12:649–659.

    Article  CAS  PubMed  Google Scholar 

  2. Nagase H, Woessner Jr, JF. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491–21494.

    Article  CAS  PubMed  Google Scholar 

  3. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803(1):55–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sennström MB, Brauner A, Byström B, Malmström A, Ekman G. Matrix metalloproteinase-8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand. 2003;82(10): 904–911.

    Article  PubMed  Google Scholar 

  5. Stygar D, Wang H, Vladic YS, et al. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod. 2002;67(3):889–894.

    Article  CAS  PubMed  Google Scholar 

  6. Watari M, Watari H, DiSanto ME, et al. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 1999;154(6): 1755–1762.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yoshida M, Sagawa N, Itoh H, et al. Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells. Mol Hum Reprod. 2001;7(10):979–985.

    Article  CAS  PubMed  Google Scholar 

  8. Ledingham MA, Denison FC, Riley SC, Norman JE. Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod. 1999;14(8):2089–2096.

    Article  CAS  PubMed  Google Scholar 

  9. Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 2002;87(3):1353–1361.

    Article  CAS  PubMed  Google Scholar 

  10. Nishihara S, Someya A, Yonemoto H, et al. Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans. Reprod Sci. 2008;15(2):156–165.

    Article  CAS  PubMed  Google Scholar 

  11. Fortunato SJ, Menon R. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes. J Assist Reprod Genet. 2002;19(10):483–486.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta. 2006; 27(11–12):1037–1051.

    Article  CAS  PubMed  Google Scholar 

  13. Roh CR, Oh WJ, Yoon BK, Lee JH. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod. 2000;6(1):96–102.

    Article  CAS  PubMed  Google Scholar 

  14. Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;183(1):94–99.

    Article  CAS  PubMed  Google Scholar 

  15. Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes. Am J Reprod Immunol. 1998;40(6):395–400.

    Article  CAS  PubMed  Google Scholar 

  16. Becher N, Hein M, Danielsen CC, Uldbjerg N. Matrix metalloproteinases and their inhibitor in the cervical mucus plug at term of pregnancy. Am J Obstet Gynecol. 2004;191(4):1232–1239.

    Article  CAS  PubMed  Google Scholar 

  17. Becher N, Hein M, Danielsen CC, Uldbjerg N. Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor. Reprod Biol Endocrinol. 2010;8:113.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Becher N, Hein M, Uldbjerg N, Danielsen CC. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP. Reprod Biol Endocrinol. 2008;6:45.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Choi SJ, Jung KL, Oh SY, Kim JH, Roh CR. Cervicovaginal matrix metalloproteinase-9 and cervical ripening in human term parturition. Eur J Obstet Gynecol Reprod Biol. 2009;142(1): 43–47.

    Article  CAS  PubMed  Google Scholar 

  20. Rahkonen L, Rutanen EM, Nuutila M, et al. Matrix metalloproteinase-8 in cervical fluid in early and mid pregnancy: relation to spontaneous preterm delivery. Prenat Diagn. 2010; 30(11):1079–1085.

    Article  CAS  PubMed  Google Scholar 

  21. Di Quinzio MK, Oliva K, Holdsworth SJ, et al. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust N Z J Obstet Gynaecol. 2007;47(1):9–15.

    Article  PubMed  Google Scholar 

  22. Heng YJ, Di Quinzio MK, Permezel M, Rice GE, Georgiou HM. Interleukin-1 receptor antagonist in human cervicovaginal fluid in term pregnancy and labor. Am J Obstet Gynecol. 2008;199(6):656.1–7.

    Article  CAS  Google Scholar 

  23. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem. 1991;198(3):775–781.

    Article  CAS  PubMed  Google Scholar 

  25. Crabbe T, Willenbrock F, Eaton D, et al. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry. 1992;31(36):8500–8507.

    Article  CAS  PubMed  Google Scholar 

  26. Miyazaki K, Funahashi K, Numata Y, et al. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J Biol Chem. 1993;268(19):14387–14393.

    CAS  PubMed  Google Scholar 

  27. Maymon E, Romero R, Pacora P, et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;182(6): 1545–1553.

    Article  CAS  PubMed  Google Scholar 

  28. Woessner JF. Matrix metalloproteinase inhibition. From The jurassic to the third millennium. Ann N Y Acad Sci. 1999;878:388–403.

    Article  CAS  PubMed  Google Scholar 

  29. Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991;277(pt 1):277–279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Heng YJ, Di Quinzio MK, Permezel M, et al. Temporal proteomic analysis of human cervicovaginal fluid with impending term labor. J Proteome Res. 2010;9(3):1344–1350.

    Article  CAS  PubMed  Google Scholar 

  31. Goldman S, Weiss A, Eyali V, Shalev E. Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod. 2003;9(6):367–373.

    Article  CAS  PubMed  Google Scholar 

  32. McLaren J, Taylor DJ, Bell SC. Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol. 2000;182(2):409–416.

    Article  CAS  PubMed  Google Scholar 

  33. Agrez M, Gu X, Giles W. Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery. Am J Obstet Gynecol. 1999;181(2):387–388.

    Article  CAS  PubMed  Google Scholar 

  34. Romero R, Chaiworapongsa T, Espinoza J, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187(5):1125–1130.

    Article  CAS  PubMed  Google Scholar 

  35. Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med. 2001;29(4):308–316.

    Article  CAS  PubMed  Google Scholar 

  36. Ota A, Yonemoto H, Someya A, et al. Changes in matrix metalloproteinase 2 activities in amnionchorions during premature rupture of membranes. J Soc Gynecol Investig. 2006;13(8):592–597.

    Article  CAS  PubMed  Google Scholar 

  37. Riley SC, Leask R, Denison FC, et al. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol. 1999;162(3): 351–359.

    Article  CAS  PubMed  Google Scholar 

  38. Pentland AP, Shapiro SD, Welgus HG. Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis. J Invest Dermatol. 1995;104(1): 52–57.

    Article  CAS  PubMed  Google Scholar 

  39. Leppert PC. Cervical softening, effacement and dilatation: a complex biochemical cascade. J Matern Fetal Med. 1992;1:213–223.

    Article  CAS  Google Scholar 

  40. Winkler M, Oberpichler A, Tschesche H, et al. Collagenolysis in the lower uterine segment during parturition at term: correlations with stage of cervical dilatation and duration of labor. Am J Obstet Gynecol. 1999;181(1):153–158.

    Article  CAS  PubMed  Google Scholar 

  41. Athayde N, Romero R, Gomez R, et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med. 1999;8(5):213–219.

    CAS  PubMed  Google Scholar 

  42. Leitich H, Egarter C, Kaider A, et al. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 1999;180(5):1169–1176.

    Article  CAS  PubMed  Google Scholar 

  43. Honest H, Bachamann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ. 2002; 325(7359):301.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol. 2009;114(3):631–640.

    Article  PubMed  Google Scholar 

  45. Imai M, Tani A, Saito M, et al. Significance of fetal fibronectin and cytokine measurement in the cervicovaginal secretions of women at term in predicting term labor and post-term pregnancy. Eur J Obstet Gynaecol Reprod Biol. 2001;97(1):53–58.

    Article  CAS  Google Scholar 

  46. Timmons BC, Mahendroo M. Processes regulating cervical ripening differ from cervical dilation and postpartum repair: insights from gene expression studies. Reprod Sci. 2007; 14(8 suppl):53–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harry M. Georgiou PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heng, Y.J., Di Quinzio, M.K.W., Liong, S. et al. Temporal Investigation of Matrix Metalloproteinases and Their Inhibitors in Human Cervicovaginal Fluid in Late Pregnancy and Labor. Reprod. Sci. 19, 55–63 (2012). https://doi.org/10.1177/1933719111413299

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719111413299

Keywords

Navigation